efficacy of ingenol mebutate with comparison to podophyllin on treatment of patients with anogenital wart.
Phase 2
Recruiting
- Conditions
- Genital wart.Anogenital (venereal) warts
- Registration Number
- IRCT20180715040482N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with untreated anogenital persistent to therapy wart
Exclusion Criteria
Immunosuppressed patients
Patients with drug reaction
Patients with other sexually transmitted diseases like herpes in the anogenital area
Pregnancy and lactation
Under 18 y/o
Treatment with other choices like cryotherapy or imiquimod in the last 4 weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients with untreated or resistant anogenital warts. Timepoint: Following up at 1,2,3 weeks and 1,3,5 months after the firs treatment. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method The frequency of repeating treatment until complete cure. Timepoint: Weekly follow up until 3 weeks, then follow up at 1,3 and 5 months after the first course of treatment. Method of measurement: Physical examination.;Duration of disease. Timepoint: The number of months the warts developed. Method of measurement: History.;Number of warts. Timepoint: Number of warts at the beginning of treatment and follow up. Method of measurement: Clinical counting.;Side effects after treatment. Timepoint: 7, 14, 21, 30,90 and 180 days after treatment. Method of measurement: Inspection and clinical examination.